CVE-2024-1165 json
Brizy – Page Builder <= 2.4.39 - Authenticated (Contributor+) Directory Traversal
published 2024-02-24 2 y ago modified 2026-06-17 4 mo ago also EUVD-2024-16933
- cvss
- 4.3
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.8%
- EPSS 0.8% chance of exploitation in 30 days, percentile 57%
- public exploits
- 0
- none known
Summary
The Brizy – Page Builder plugin for WordPress is vulnerable to Directory Traversal in all versions up to, and including, 2.4.39 via the 'id'. This makes it possible for authenticated attackers, with contributor-level access and above, to upload files to arbitrary locations on the server
Patch / fix
- brizy brizy-page_builder 2.4.41
- brizy brizy 2.4.41
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- partial
- Assessed
- 2 y ago
Exploit prediction
0.82% chance of exploitation in the next 30 days, higher than 57% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 4.3 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N |
| NVD | 3.1 | 6.5 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N |
Affected products
- themefusecom Brizy – Page Builder
Classification
- Weakness
-
- CWE-22 Improper Limitation of a Pathname to a Restricted Directory
- Technology feeds
References
-
plugins.trac.wordpress.org
/changeset/3034945/brizy/tags/2.4.41/editor/screenshot/manager.php
patch
-
wordfence.com
/threat-intel/vulnerabilities/id/7673b2ba-5d7a-4ae9-92e7-1a910687fdb8?source=cve
third-party-advisory
-
plugins.trac.wordpress.org
/browser/brizy/tags/2.4.39/editor/screenshot/manager.php#L33
product
Sources
- CVE List CVE-2024-1165
- NVD CVE-2024-1165
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.
CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.